• Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

  • Apr 3 2025
  • Duración: 11 m
  • Podcast

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.

    During their conversation, Dr. Morice and Dr. Tan explore:

    • Inspiration for developing the liquid biopsy.
    • Features that differentiate LiquidHALLMARK® from existing cancer tests.
    • Patients who will benefit from the test and how an oncologist might use the results.
    • The future potential of liquid biopsy advancements.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles